Can Curaleaf Holdings (TSX:CURA) Justify Its Valuation Following Its Latest Store Expansion?

Curaleaf Holdings expansion puts fresh focus on the stock

Curaleaf Holdings (TSX:CURA) has been busy. The business recently relocated dispensaries in Connecticut and Pennsylvania and opened a new store in Port Richey, Florida, keeping its 179 location footprint intact.

These openings have coincided with a sharp rebound in sentiment around Curaleaf Holdings, with the share price at CA$16.36 after a 1-day share price return of 11.29% and a year-to-date share price return of 52.33%, even though the 5-year total shareholder return is still down 64.26%. This suggests momentum has recently been building from a low base.

Scan hand picked cannabis peers showing strong balance sheets and consistent execution with the list of solid balance sheet and fundamentals (7 results) while Curaleaf Holdings' expansion story plays out.

After Curaleaf Holdings climbed sharply from a beaten up five year record, the tension now is simple. Is the recent surge the main course or just the appetizer before valuation does more of the work?

Most Popular Narrative: 12% Undervalued

Curaleaf Holdings last closed at CA$16.36, while the most followed valuation narrative pegs fair value at CA$18.54 using a 6.62% discount rate. That gap frames a story where international expansion and efficiency gains carry a lot of weight in how the stock is being priced.

Ongoing vertical integration and supply chain optimization, including leveraging cultivation facilities in Portugal and bringing beverage fulfillment in-house for the hemp business, are expected to reduce operating costs and enhance margins over time, directly supporting stronger EBITDA and potential margin expansion.

See why 17 investors see Curaleaf Holdings as 12% undervalued.

On this view, Curaleaf Holdings trades at a discount of about 12% to that CA$18.54 fair value estimate. The narrative hinges on revenue of roughly US$1.7b and earnings of US$195.2m by around 2029 alongside a future P/E of about 24x. The same framework also assumes revenue growth near 9.6% a year, higher profit margins over time and a modest rise in shares on issue, all filtered through that 6.62% required return.

Analysts contributing to this narrative also flag that Curaleaf Holdings is currently loss making, with net income of US$41.2m in the red, and not forecast to reach profitability over the next three years in their base case. That underlines how much of the CA$18.54 value comes from longer term expectations rather than near term earnings, and why any change in tax rules, pricing pressure or international rollout could shift the story quickly.

For readers weighing this against the current CA$16.36 share price, the key judgement is whether those margin and growth assumptions look realistic given today’s loss, sector competition and the company’s use of higher risk funding sources. If the narrative plays out, the implied fair value suggests upside from here. If execution on international markets or regulatory outcomes fall short, the present discount could prove fragile.

Result: Fair Value of CA$18.54 (UNDERVALUED)

Still, the Curaleaf Holdings story leans heavily on international expansion and higher margin assumptions, so any regulatory setbacks or ongoing pricing pressure could quickly undercut that 12% undervaluation case.

Find out about the key risks to this Curaleaf Holdings narrative.

Next Steps

Investors are divided on whether Curaleaf Holdings is a comeback story or a value trap in progress. Use the full set of signals to stress test your own thesis and weigh both sides of the ledger by checking the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Curaleaf Holdings?

If you stop with Curaleaf Holdings, you only see one angle. Cast a wider net with other ideas that match your risk appetite and return goals.

• Hunt for quality at a discount by scanning companies that screen as attractively priced on cash flows and fundamentals using the 7 high quality undervalued stocks.
• Build a steadier income stream by reviewing higher yielding payers that focus on consistency and financial resilience through the 1 dividend fortresses.
• Dial down portfolio risk by focusing on financially robust businesses with strong balance sheets using the 8 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com